Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma

标题
Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma
作者
关键词
-
出版物
JOURNAL OF CLINICAL ONCOLOGY
Volume 35, Issue 19, Pages 2125-2132
出版商
American Society of Clinical Oncology (ASCO)
发表日期
2017-04-26
DOI
10.1200/jco.2016.72.1316

向作者/读者发起求助以获取更多资源

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now